Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J. G. D'Haese"'
Autor:
E. Pretzsch, J. G. D’Haese, B. Renz, M. Ilmer, T. Schiergens, R. C. Miksch, M. Albertsmeier, M. Guba, M. K. Angele, J. Werner, H. Nieß
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The importance of platelets in the pathogenesis of metastasis formation is increasingly recognized. Although evidence from epidemiologic studies suggests positive effects of aspirin on metastasis formation, there is little clinica
Externí odkaz:
https://doaj.org/article/07da99dc09704619a84ce49c78f1e771
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 91(9)
Cystic tumors of the pancreas (PCN) have increasingly gained importance in the clinical routine as they are frequently diagnosed as an incidental finding due to the continuous improvement in cross-sectional imaging. A differentiation is made between
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 91(8)
Most patients with pancreatic cancer suffer a relapse, which occurs either locally or systemically in the sense of liver and the lung metastases. Surgery for pancreatic cancer has become more radical due to the increased use of multimodal treatment c
Publikováno v:
Der Internist. 60(3)
With an increasing number of hospital admissions, an average of 16-to 20 days in hospital per year, 34% of patients constantly taking pain medication, 57% in need of enzyme supplementation, and 29% with diabetes mellitus, chronic pancreatitis is a de
Autor:
J. Werner, J. G. D'Haese
Publikováno v:
Der Radiologe. 56:318-324
Pancreatic cancer is notoriously one of the most aggressive cancers and still has a poor prognosis. Surgical resection is the only chance for a curative therapy approach, with which at least a 5aEuroyear survival can be achieved for 25 % of patients.
Autor:
J G, D'Haese, J, Werner
Publikováno v:
Der Radiologe. 56(4)
Pancreatic cancer is notoriously one of the most aggressive cancers and still has a poor prognosis. Surgical resection is the only chance for a curative therapy approach, with which at least a 5‑year survival can be achieved for 25% of patients. Re
Autor:
Beyer G; Medical Department II, University Hospital, Ludwig Maximilians-University, Munich, Germany., Goni E; Medical Department II, University Hospital, Ludwig Maximilians-University, Munich, Germany., Köpke M; Medical Department II, University Hospital, Ludwig Maximilians-University, Munich, Germany., G D'Haese J; Department of Surgery, University Hospital, Ludwig Maximilians-University, Munich, Germany., Werner J; Department of Surgery, University Hospital, Ludwig Maximilians-University, Munich, Germany., Schirra J; Medical Department II, University Hospital, Ludwig Maximilians-University, Munich, Germany., Mayerle J; Medical Department II, University Hospital, Ludwig Maximilians-University, Munich, Germany.
Publikováno v:
Visceral medicine [Visc Med] 2018 Jul; Vol. 34 (3), pp. 197-201. Date of Electronic Publication: 2018 Jun 13.